Related Experiment Video
Updated: Jun 23, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Mutagenicity studies with N-acetyl-L-aspartic acid
Sule Karaman1, Abby Myhre, E Maria Donner
1DuPont Company, Toxicology, 2450 SE Oak Tree Ct., Ankeny, IA 50021, USA.
N-acetyl-L-aspartic acid (NAA), found in foods, was tested for mutagenicity. Standard in vitro and in vivo tests showed no mutagenic effects for NAA or its metabolite L-aspartate (ASP), indicating no safety concern.
Area of Science:
- Biochemistry
- Toxicology
- Food Safety
Background:
- N-acetyl-L-aspartic acid (NAA) is a compound found in various food products at low concentrations.
- Assessing the safety of food components, including NAA, is crucial for public health.
- NAA is metabolized into L-aspartate (ASP), a common amino acid.
Purpose of the Study:
- To evaluate the mutagenic potential of N-acetyl-L-aspartic acid (NAA).
- To determine if NAA poses a mutagenicity risk in the context of dietary intake.
- To compare the mutagenicity of NAA with its metabolite, L-aspartate (ASP).
Main Methods:
- Conducted in vitro bacterial mutagenicity tests following OECD guidelines.
- Performed in vivo mammalian mutagenicity studies to assess clastogenicity.
- Utilized L-aspartate (ASP) as a control due to its metabolic relationship with NAA.
Main Results:
- No evidence of mutagenicity was detected in the in vitro bacterial assays for either NAA or ASP.
- No mutagenic or clastogenic effects were observed in the in vivo mammalian studies for NAA or ASP.
- The combined in vitro and in vivo approaches provided comprehensive data for hazard assessment.
Conclusions:
- N-acetyl-L-aspartic acid (NAA) does not exhibit mutagenic properties.
- The presence of NAA in food is unlikely to pose a mutagenicity risk to consumers.
- Dietary intake of NAA can be considered safe from a mutagenicity perspective.
Related Concept Videos
Mutagenicity and Carcinogenicity
In vitro Mutagenesis
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
In-vitro Mutagenesis
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Spontaneous and Induced Mutations

